Natural language processing models that analyze the exact words children use when talking about stressful events prove better at predicting future mental health problems than a panel of human experts, according to a study published in Nature Mental Health. Researchers at Stanford’s School of Humanities and Sciences found that evaluating recorded interviews of more than … Read more
Brain-computer interfaces (BCIs) are shifting from restoring physical movement to treating complex cognitive disorders. According to Dr. Ignacio Saez of the Icahn School of Medicine at Mount Sinai, the next generation of these devices will target conditions like depression, PTSD, and anxiety by functioning as closed-loop systems that detect and regulate dysfunctional brain states in … Read more
Emerging research indicates that immune system dysregulation significantly influences the development of psychiatric disorders, including major depressive disorder (MDD) and schizophrenia. According to findings published in Cells (2025) and Current Opinion in Genetics & Development (2026), while immune signatures—such as elevated C-reactive protein (CRP) and interleukin-6 (IL-6)—are not present in every patient, they appear to … Read more
Eli Lilly and Company is acquiring biotech firm AtaiBeckley for an up-front payment of $2.8 billion to integrate the psychedelic drug candidate BPL-003 into its neuroscience portfolio. According to company terms, Lilly will pay $6.75 per outstanding share, with potential milestone payments reaching an additional $1 billion ($2.50 per share), according to the deal terms. … Read more
Medical cannabis is now legal in 47 states and Washington, D.C., but a disconnect remains between cancer survivors using the substance to manage symptoms and the providers treating them. According to a study published in the Journal of Cancer Education, while survivors often turn to cannabis for pain, nausea, and anxiety, they frequently report feeling … Read more
Regularly sleeping nine to 10 hours or more per night is linked to higher levels of p-tau181, a blood-based protein marker for Alzheimer’s disease, according to a study from UT Health San Antonio. Researchers found that the association becomes most pronounced beyond 10 hours of sleep, suggesting long sleep may be an early indicator of … Read more
Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more
Early menopause affects approximately 1 in 14 women aged 30 to 49 in low and middle income countries, according to a pooled data analysis of 44 nations published in BMJ Global Health. The study finds that prevalence is consistently higher in rural areas, while higher education levels and delayed childbearing significantly reduce the risk. Why … Read more
Summer seasonal affective disorder (RSAD) is a form of clinical depression that affects an estimated 0.57% of people, according to an analysis of multiple studies. Unlike winter SAD, which triggers low moods during cold months, RSAD manifests as anxiety, insomnia, and fatigue during the heat of summer. What causes summer seasonal affective disorder? Melatonin levels … Read more
Creatine monohydrate, a supplement widely used for muscle performance, may assist in treating major depressive disorder, according to a recent systematic review published in the journal Brain Medicine. Researchers found that while the supplement shows promise as an add-on therapy, the current evidence remains preliminary and requires further large-scale clinical trials before it can be … Read more